Normalizing adiponectin levels in obese pregnant mice prevents adverse metabolic outcomes in offspring. Issue 2 (22nd October 2018)

• Record Type: Journal Article
• Authors: Paulsen, Megan E.; Rosario, Fredrick J.; Wesolowski, Stephanie R.; Powell, Theresa L.; Jansson, Thomas
• Is Part Of: FASEB journal. Volume 33:Issue 2(2019)
• Page Start: 2899
• Page End: 2909
• Publication Date: 2018-10-22
• Subjects: fetal programming -- insulin resistance -- fatty liver; Biology -- Periodicals; Biology, Experimental -- Periodicals; 570
• DOI: 10.1096/fj.201801015R
• Languages: English
• ISSNs: 0892-6638

Abstract

ABSTRACT: Infants of obese mothers have an increased risk of developing obesity, insulin resistance, and type 2 diabetes. The underlying mechanisms remain elusive, and no effective interventions to limit the transmission of metabolic disease from the obese mother to her infant are currently available. Obese pregnant women have decreased circulating levels of adiponectin, which is associated with increased placental nutrient transport and fetal overgrowth. We have reported that normalization of adiponectin levels during late gestation reversed placental dysfunction and fetal overgrowth in a mouse model of maternal obesity in pregnancy. In the current study, we hypothesized that adiponectin supplementation during pregnancy in obese mice attenuates the adverse metabolic outcomes in adult offspring. Adult male offspring of obese mice developed obesity, fatty liver, and insulin resistance, with adult female offspring of obese mice having a less pronounced metabolic phenotype. These metabolic abnormalities in offspring born to obese mice were largely prevented by normalization of maternal adiponectin levels in late pregnancy. We provide evidence that low circulating maternal adiponectin is a critical mechanistic link between maternal obesity and the development of metabolic disease in offspring. Strategies aimed at improving maternal adiponectin levels may prevent long‐term metabolic dysfunction in offspring of obese mothers.—Paulsen, M. E., Rosario, F. J., Wesolowski, S. R., Powell, T. L., Jansson, T. Normalizing adiponectin levels in obese pregnant mice prevents adverse metabolic outcomes in offspring. FASEB J. 33, 2899–2909 (2019). www.fasebj.org